| pubmed-article:16005141 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16005141 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:16005141 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:16005141 | lifeskim:mentions | umls-concept:C1704272 | lld:lifeskim |
| pubmed-article:16005141 | lifeskim:mentions | umls-concept:C0215993 | lld:lifeskim |
| pubmed-article:16005141 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:16005141 | pubmed:dateCreated | 2005-9-13 | lld:pubmed |
| pubmed-article:16005141 | pubmed:abstractText | Hepatocyte growth factor activator (HGFA) is responsible for proteolytic activation of the precursor form of hepatocyte growth factor (HGF). We attempted to clarify whether serum levels of HGFA could be used as a marker for prostate cancer. | lld:pubmed |
| pubmed-article:16005141 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16005141 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16005141 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16005141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16005141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16005141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16005141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16005141 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16005141 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16005141 | pubmed:issn | 0302-2838 | lld:pubmed |
| pubmed-article:16005141 | pubmed:author | pubmed-author:AkashiTakuyaT | lld:pubmed |
| pubmed-article:16005141 | pubmed:author | pubmed-author:FuseHidekiH | lld:pubmed |
| pubmed-article:16005141 | pubmed:author | pubmed-author:NagakawaOsamu... | lld:pubmed |
| pubmed-article:16005141 | pubmed:author | pubmed-author:JunichoAkiraA | lld:pubmed |
| pubmed-article:16005141 | pubmed:author | pubmed-author:FujiuchiYasuy... | lld:pubmed |
| pubmed-article:16005141 | pubmed:author | pubmed-author:NagaikeKazuhi... | lld:pubmed |
| pubmed-article:16005141 | pubmed:author | pubmed-author:YamagishiTosh... | lld:pubmed |
| pubmed-article:16005141 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16005141 | pubmed:volume | 48 | lld:pubmed |
| pubmed-article:16005141 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16005141 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16005141 | pubmed:pagination | 686-90 | lld:pubmed |
| pubmed-article:16005141 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:meshHeading | pubmed-meshheading:16005141... | lld:pubmed |
| pubmed-article:16005141 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16005141 | pubmed:articleTitle | Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostate cancer. | lld:pubmed |
| pubmed-article:16005141 | pubmed:affiliation | Department of Urology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan. nagakawa@ms.toyama-mpu.ac.jp | lld:pubmed |
| pubmed-article:16005141 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16005141 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16005141 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16005141 | lld:pubmed |
